Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SMS Pharmaceuticals Ltd Updates On Sale And Transferred Of Unit-VI To Mylan Laboratories Limited


Thursday, 21 Feb 2013 01:58am EST 

SMS Pharmaceuticals Ltd announced that as per Business Transfer Agreement dated October 16, 2012, with Mylan Laboratories Limited (Mylan), the Company have sold/transferred the facility situated at Plot No. 28, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam, A.P. 

Company Quote

405.8
-4.25 -1.04%
26 Dec 2014